Santhera Pharmaceuticals announced that Chairman of the Board Elmar Schnee will not stand for re-election at the upcoming Annual General Meeting on June 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.77 CHF | -1.01% | +5.17% | -0.41% |
25/04 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
25/04 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.41% | 124M | |
+16.20% | 78.51B | |
+13.69% | 9B | |
+42.06% | 4.96B | |
-14.54% | 4.84B | |
+9.01% | 3.72B | |
+21.94% | 2.48B | |
-27.22% | 2.19B | |
+15.83% | 2.12B | |
-39.50% | 1.94B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Pharmaceuticals Holding AG Announces that Elmar Schnee will not stand for re-election at the upcoming Annual General Meeting